Reviva Pharmaceuticals (RVPH) - 2020 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2020 (Exact name of registrant as specified in its charter) Delaware 85-4306526 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 19925 Stevens Creek Blvd., Suite 100 Cupertino, CA 95014 95014 (Address of principal executive offices) (Zip c ...